NHS Fife is in joint consultation with Harminder Shergill T/A Dalgety Healthcare regarding their proposed application for a new pharmacy to open within Dalgety Bay.
NHS Fife has to decide whether granting of the application would be necessary or desirable in order to secure adequate provision of pharmaceutical services in the neighbourhood in which the premises are located by persons whose names are included in the pharmaceutical list.
Harminder Shergill T/A Dalgety Healthcare who wishes to submit the application has defined the neighbourhood as Dalgety Bay in its entirety.
Harminder Shergill T/A Dalgety Healthcare proposes to provide the following services from the pharmacy should the application be granted:
- Chronic Medication Service
- Acute Medication Service
- Minor Ailment Service
- Public Health Service (Smoking Cessation Services and Sexual Health Services)
- Unscheduled Care – urgent supply of repeat medicines and appliances
Substance misuse:
- Supervised self-administration of Methadone
- Supervised self-administration of Buprenorphine
- Injection Equipment Provision*
- Pharmaceutical Advice to Care Homes
- Palliative Care Network*
- Gluten-Free Foods
- Stoma Care
- Disposal of Patients’ Unwanted Medicines
- Just in Case Programme*
(* Should NHS Fife determine there is a requirement)
You can make your views known on the proposed pharmacy by participating in the public consultation survey.
Paper copies of the questionnaire can also be obtained by contacting primary care administration by email at Fife-UHB.primarycareadmin@nhs.net or by telephone on 01592 226 413. Responses must be received by NHS Fife no later than 5pm on 28th June.
